Form 4: Pfizer Director Scott Gottlieb Acquires Phantom Stock

Pfizer Inc. director Scott Gottlieb was granted 7,686.539 phantom stock units as part of the company's deferred compensation plan for non-employee directors.

Summary

• Director Scott Gottlieb received an award of 7,686.539 phantom stock units on April 23, 2026.
• The units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
• Each phantom unit represents one share of common stock, valued at $26.67 per unit.
• Following this transaction, the director's total beneficial ownership of phantom stock units increased to 57,001.814.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or strategy.

Positives

• Director compensation alignment through equity-linked instruments encourages long-term commitment to company performance.

Negatives

• None identified; this is a standard director compensation disclosure.

Risks

• The value of the phantom stock units is tied to the future performance of Pfizer common stock.

Future Outlook

The units are settled in cash or common stock at the director's election following their retirement from the Board of Directors.

Industry Context

StockSavvy.ai notes that director compensation via deferred stock units is a common governance practice in the pharmaceutical industry to ensure board members maintain a vested interest in long-term shareholder value.

Comparison to Industry Standards

• The use of deferred compensation plans for non-employee directors is consistent with standard corporate governance practices at large-cap pharmaceutical companies like Merck, Bristol Myers Squibb, and Eli Lilly.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard component of director remuneration.

Next Steps

• The units will be settled upon the director's retirement from the Board.

Key Dates

Keywords

Pfizer, PFE, Scott Gottlieb, Form 4, Director Compensation, Insider Trading, Phantom Stock